Euclidean Capital

Organization · Investor

Minutes holds 1 deal naming Euclidean Capital.

Deals in Minutes

Deals naming Euclidean Capital
Company	Deal	Amount	Counterparties	Date ↓	Status
Actio BiosciencesBiotech	FundingSeries A	$55M	Led by Canaan, DROIA VenturesWith Deerfield Management, EcoR1 +1	12 Sep 2023	Closed

Actio Biosciences$55M
FundingSeries A, led by Canaan +4
Biotech · 12 Sep 2023 · Closed

Showing 1–1 of 1

1 deal Minutes has recorded

Rounds recorded since 2023

Rounds recorded since 2023; a round in two industries counts in each

Rounds recorded since 2023, by the company's headquarters region

Rounds naming this investor that Minutes has recorded
Date	Company	Round	Amount	Role	Outcome
12 September 2023	Actio Biosciences Healthcare · North America	Series A	$55M	Joined	Acquired by Jazz Pharmaceuticals · Sep 2026

1 of 1

Each exit, with the rounds Euclidean Capital joined before it

Euclidean Capital joined: Series A

Returns not shown: Minutes does not hold stake sizes unless a party discloses them.

Canaan1 round togetherSep 12, 2023

DROIA Ventures1 round togetherSep 12, 2023

Deerfield Management1 round togetherSep 12, 2023

EcoR11 round togetherSep 12, 2023

No developments name Euclidean Capital yet.